Inventor · disambiguated record
Jong Yeon Hwang
Also filed as: HWANG JONG YEON
12 granted patents·7 pending applications·11 citations·filing 2003–2024
83Inventor score
Top patents by PatentIndex Score
19 records- 0179US11192878B2Piperidine-2,6-dione derivative and use thereofKOREA RES INST CHEMICAL TECH·Filed 2018·Granted Dec 7, 2021·3 cites·5 claims
- 0277US11084824B2Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredientKOREA RES INST CHEMICAL TECH·Filed 2018·Granted Aug 10, 2021·2 cites·6 claims
- 0375US2025082762A1Novel bifunctional heterocyclic compound having btk degradation function via ubiquitin proteasome pathway, and use thereofKOREA RES INST CHEMICAL TECH·Filed 2024·Application pending·0 cites
- 0475US2025073341A1Bifunctional heterocyclic compound having btk degradation function via ubiquitin proteasome pathway, and use thereofKOREA RES INST CHEMICAL TECH·Filed 2024·Application pending·0 cites
- 0570US10265744B2Rolling apparatus, continuous casting and rolling apparatus and methodPOSCO·Filed 2013·Granted Apr 23, 2019·1 cites·14 claims
- 0669US7371874B26-Alkylamino-2-methyl-2′-(N-methyl substituted sulfonamido)methyl-2H-1-benzopyran derivative as anti-inflammatory inhibitorKOREA RES INST CHEM TECH·Filed 2006·Granted May 13, 2008·3 cites·4 claims
- 0767US12161722B2Bifunctional heterocyclic compound having BTK degradation function via ubiquitin proteasome pathway, and use thereofKOREA RES INST CHEMICAL TECH·Filed 2022·Granted Dec 10, 2024·0 cites·2 claims
- 0863US10053458B2Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredientKOREA RES INST CHEMICAL TECH·Filed 2015·Granted Aug 21, 2018·1 cites·10 claims
- 0960US7368575B26-alkylamino-2,2′-disubstituted-7,8-disubstituted-2H-1-benzopyran derivatives as 5-lipoxygenase inhibitorKOREA RES INST CHEM TECH·Filed 2004·Granted May 6, 2008·1 cites·3 claims
- 1060US2025346575A1Isoindolinone derivative having glutarimide mother nucleus, and use thereofKOREA RES INST CHEMICAL TECH·Filed 2022·Application pending·0 cites
- 1155US2024252488A1Mlkl binding or degrading compound and pharmaceutical use thereofKOREA RES INST CHEMICAL TECH·Filed 2021·Application pending·0 cites
- 1251US2024018123A1Compound for inhibiting or disintegrating androgen receptor, and pharmaceutical use thereofKOREA RES INST CHEMICAL TECH·Filed 2021·Application pending·0 cites
- 1348US2022105188A1Target protein eed degradation-inducing degraducer, preparation method thereof, and pharmaceutical composition for preventing or treating diseases related to eed, ezh2, or prc2, comprising same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2020·Application pending·0 cites
- 1445US11053225B2Pyrimidine derivative compound, optical isomer thereof, or pharmaceutically acceptable salt thereof, and composition for preventing or treating Tyro 3 related disease comprising same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2018·Granted Jul 6, 2021·0 cites·10 claims
- 1542US6908942B26-amino-2,2-dimethyl-3,4,6-trisubstituted benzopyran derivatives and their construction by parallel synthesis on solid-phaseKOREA RES INST CHEM TECH·Filed 2003·Granted Jun 21, 2005·0 cites·4 claims
- 1638US2018133785A1Solidification apparatusPOSCO·Filed 2016·Application pending·0 cites
- 1735US10369149B24-(2-amino-tetrahydronaphthalenyl)pyrimidine derivative, preparation method therefor, and pharmaceutical composition for preventing or treating cancer, containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2015·Granted Aug 6, 2019·0 cites·9 claims
- 1835US10100019B2N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2016·Granted Oct 16, 2018·0 cites·4 claims
- 1926US9809602B2Compounds for treating viral infectionsPASTEUR INSTITUT KOREA·Filed 2015·Granted Nov 7, 2017·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →